Stairlifts Market: Foresees Skyrocketing Growth in the Coming Years Ventricular Assist Devices Market

Ventricular Assist Devices Market - Global
Industry Insights, Trends, Outlook, and
Opportunity Analysis, 2018-2026
Ventricular assist devices are external devices attached to a patient’s body, which helps to pump
blood to whole body. It is principally used in case of patients with heart failure. It is a high-end device
that mimics the function of the heart. Heart failure is a condition in which heart muscles weaken, and
thus unable to pump sufficient amount of blood to body. Various conditions such as heart attacks,
high blood pressure, defective heart valves, irregular heart rhythms, diabetes, and chronic kidney and
lung diseases cause heart failure. Medication, implantable heart devices (pacemakers), and heart
transplantation are some of the options for treatment of heart failure. However, these approaches
have limitations that may lead to advanced heart failure condition, thereby increasing the demand for
ventricular assist devices (VADs). VADs lowers the work load on failing heart and help in maintaining
smooth blood flow to vital organs. These devices were originally designed to temporarily assist
surgeons while performing transplant surgeries or while treating other medical problems. However,
VADs eventually emerged as a pioneer life support for patients suffering from the final stage of heart
failure. VADs consist of three parts namely, inflow pipe that receives blood from ventricles, pump that
pulls blood from ventricles and pushes it into outflow pipe that carries blood to aorta to supply blood
to body
Request Sample Copy of Research Report:
https://www.coherentmarketinsights.com/insight/request-sample/1686
Regional Insights
Ventricular assist devices market is geographically divided into North America, Latin America,
Europe, Asia Pacifc, Middle East, and Africa. The market in North America is expected to hold a
dominant position in the VADs market during forecasted period due to high prevalence of heart
failure and afordaaility of these devices in the region. According to a study pualished in the
Journal Circulation in 2016, over 5.7 million people in the U.S. sufered sufering from HF (heart
failure), which is expected to increase to 8 million ay 2030 and over 250,000 patients are
expected to develop advanced heart failure, thus requiring VADs. Shortage of heart donors in the
U.S. is also expected to drive growth of the market. According to statistics provided ay the
American College of Cardiology in 2017, only 2,200 heart donor are availaale each year in the